Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents

被引:37
作者
Kobayashi, H
Kawamoto, S
Saga, T
Sato, N
Hiraga, A
Ishimori, T
Konishi, J
Togashi, K
Brechbiel, MW
机构
[1] Kyoto Univ, Grad Sch Med, Dept Diagnost & Intervent Imagiol, Sakyo Ku, Kyoto 6068507, Japan
[2] Dept Nucl Med & Diagnost Imaging, Kyoto, Japan
[3] Kyoto Univ, Dept Radiol, Kyoto, Japan
[4] Otsu Municipal Hosp, Dept Radiol, Otsu, Shiga, Japan
[5] NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
macromolecular; MRI; contrast agent; polyamidoamine dendrimer; polyethylene glycol;
D O I
10.1002/mrm.1257
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Macromolecules conjugated with polyethylene glycol (PEG) acquire more hydrophilicity, resulting In a longer half-life in circulation and lower Immunogenicity. Two novel conjugates for MRI contrast agents were synthesized from a generation-4 polyamidoamine dendrimer (G4D), 2-(p-isothiocyanatobenzyl)-6-methyl-diethylenetriaminepentaacetic acid (1B4M), and one or two PEG molecules with a molecular weight of 20000 Da (PEG(2)-G4D-(1B4M-Gd)(62) (MW: 96 kD), PEG(1)-G4D-(1B4M-Gd)(63) (MW: 77 kD)), Their pharmacokinetics, excretion, and properties as vascular MRI contrast agents were evaluated and compared with those of G4D-(1B4M-Gd)(64) (MW: 57 kD). PEG(2)-G4D-(1B4M-Gd)(62) remained in the blood significantly longer and accumulated significantly less in the liver and kidney than the other two preparations (P < 0.01). Although the blood clearance was slower, PEG(2)-G4D-(1B4M-Gd)(62) was excreted more readily without renal retention than the other two preparations. In conclusion, the positive effects of PEG conjugation on a macromolecular MRI contrast agent were found to be prolonged retention in the circulation, Increased excretion, and decreased accumulation in the organs. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:781 / 788
页数:8
相关论文
共 43 条
[1]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[2]  
Adzamli K, 1997, ACTA RADIOL, V38, P73
[3]   BORONATED STARBURST DENDRIMER MONOCLONAL-ANTIBODY IMMUNOCONJUGATES - EVALUATION AS A POTENTIAL DELIVERY SYSTEM FOR NEUTRON-CAPTURE THERAPY [J].
BARTH, RF ;
ADAMS, DM ;
SOLOWAY, AH ;
ALAM, F ;
DARBY, MV .
BIOCONJUGATE CHEMISTRY, 1994, 5 (01) :58-66
[4]   IMMUNOGENICITY OF GADOLINIUM-BASED CONTRAST AGENTS FOR MAGNETIC-RESONANCE-IMAGING - INDUCTION AND CHARACTERIZATION OF ANTIBODIES IN ANIMALS [J].
BAXTER, AB ;
MELNIKOFF, S ;
STITES, DP ;
BRASCH, RC .
INVESTIGATIVE RADIOLOGY, 1991, 26 (12) :1035-1040
[5]   MAGNETIC-RESONANCE-IMAGING DETECTION OF AN EXPERIMENTAL PULMONARY PERFUSION DEFICIT USING A MACROMOLECULAR CONTRAST AGENT - POLYLYSINE-GADOLINIUM-DTPA(40) [J].
BERTHEZENE, Y ;
VEXLER, V ;
PRICE, DC ;
WISNERDUPON, J ;
MOSELEY, ME ;
AICHER, KP ;
BRASCH, RC .
INVESTIGATIVE RADIOLOGY, 1992, 27 (05) :346-351
[6]   A NEW MACROMOLECULE AS A CONTRAST AGENT FOR MR-ANGIOGRAPHY - PREPARATION, PROPERTIES, AND ANIMAL STUDIES [J].
BOGDANOV, AA ;
WEISSLEDER, R ;
FRANK, HW ;
BOGDANOVA, AV ;
NOSSIF, N ;
SCHAFFER, BK ;
TSAI, E ;
PAPISOV, MI ;
BRADY, TJ .
RADIOLOGY, 1993, 187 (03) :701-706
[7]   Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body [J].
Bourne, MW ;
Margerun, L ;
Hylton, N ;
Campion, B ;
Lai, JJ ;
Derugin, N ;
Higgins, CB .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1996, 6 (02) :305-310
[8]  
Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO
[9]  
2-J
[10]  
Deckert PM, 2000, INT J CANCER, V87, P382, DOI 10.1002/1097-0215(20000801)87:3<382::AID-IJC12>3.3.CO